Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Development and commercialization of therapies for patients with rare diseases130.13M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States96.11M73.86%
International34.02M26.14%